Allied Market Research published a report, titled, "Deferiprone Market by Form (Tablets and Others), Application ...

There was panic yesterday at the University of Benin Teaching Hospital (UBTH) following the death of an infant allegedly linked to the ongoing rubella measles ...

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...

Health experts and patient advocates have raised concerns over Nigeria’s growing Non-Communicable Disease (NCD) crisis, calling for urgent government ...

Today’s Forbes Daily also covers Anthropic’s hot streak, a junk bond master, Les Wexner’s upcoming Epstein deposition, cutting edge bobsled engineering and more.

Lakota West’s win over Princeton at Cintas Center, a night that felt like a preview of March. Richardson scored 12 points and handed out three assists as the Firebirds snapped Princeton’s win streak ...

Before his first semester teaching at California Lutheran University, adjunct faculty member JD Slajchert had already lived a dozen stories worth telling. Now, the Emmy-nominated professor and TEDx ...

Season 2 of HBO’s “The Pitt” began streaming in January after winning Best Drama Series and four more awards at the 2025 Primetime Emmy awards for its first season. Both seasons follow a full shift at ...

Recent therapies like hydroxyurea (Droxia, Bristol-Myers Squibb), the first FDA-approved drug for SCD in 1994, increase fetal hemoglobin (HbF), which, through unknown pathways, improves SCD symptoms ...

WNCT’s Erin Jenkins sits down with a sickle cell disease survivor and a doctor to learn more about how far their research has ...

WNCT’s Erin Jenkins sits down with a sickle cell disease survivor and a doctor to learn more about how far their research has come.

Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small ...